20-year expertise on prenatal analysis in a reference college medical genetics center in Turkey

Barriers and methods to combine medical genetics and main care in underserved populations: a scoping overview
Despite medical and technological advances, critical gaps stay in delivering genetic companies on account of disparities in workforce distribution and lack of protection for genetic testing and counseling. Genetic companies supply, notably in medically underserved populations, might rely closely on main care suppliers (PCPs). This study goals to establish boundaries to integrating genetic companies and main care, and methods to assist integration, by conducting a scoping overview.
Literature synthesis discovered boundaries most regularly cited by PCPs together with inadequate information about genetics and danger evaluation, lack of entry to geneticists, and inadequate time to deal with these challenges. Telegenetics, patient-centered care, and studying communities are methods to beat these boundaries. Telegenetics dietary supplements face-to-face clinics by offering distant entry to genetic companies. It can also be used for doctor consultations and schooling. Patient-centered care permits suppliers, households, and sufferers to coordinate companies and sources. Access to skilled data gives a important useful resource for PCPs.
Anti-Tissue Factor/F3 Antibody |
|||
PB9701 | BosterBio | 100ug/vial | EUR 294 |
Anti-Tissue Factor/F3 Antibody |
|||
PB9702 | BosterBio | 100ug/vial | EUR 294 |
Anti-Tissue Factor (4G4) |
|||
YF-MA12922 | Abfrontier | 100 ug | EUR 363 |
Description: Mouse monoclonal to Tissue Factor |
Anti-Tissue Factor (4G4) |
|||
YF-MA12923 | Abfrontier | 200 ul | EUR 363 |
Description: Mouse monoclonal to Tissue Factor |
Anti-Tissue Factor Rabbit Monoclonal Antibody |
|||
M00342 | BosterBio | 100ug/vial | EUR 397 |
Description: Rabbit Monoclonal Tissue Factor Antibody. Validated in IF, IHC-P, ICC, WB and tested in Human, Mouse, Rat. |
Anti-Connective Tissue Growth Factor antibody |
|||
STJ73587 | St John's Laboratory | 100 µg | EUR 359 |
Anti-Tissue Factor Pathway Inhibitor antibody |
|||
STJ70019 | St John's Laboratory | 100 µg | EUR 359 |
Tissue Factor Antibody |
|||
49112-100ul | SAB | 100ul | EUR 333 |
Tissue Factor Antibody |
|||
49112-50ul | SAB | 50ul | EUR 239 |
Tissue Factor antibody |
|||
20R-1401 | Fitzgerald | 10 mg | EUR 303 |
Description: Sheep polyclonal Tissue Factor antibody |
Sheep anti-Human Tissue Factor polyclonal antibody |
|||
CABT-L422 | Creative Diagnostics | 10 mg | EUR 663 |
Sheep anti-Human Tissue Factor polyclonal antibody |
|||
CABT-L423 | Creative Diagnostics | 200ug | EUR 663 |
Mouse anti-Human Tissue Factor monoclonal antibody |
|||
CABT-L424 | Creative Diagnostics | 100ug | EUR 663 |
Mouse anti-Human Tissue Factor monoclonal antibody |
|||
CABT-L425 | Creative Diagnostics | 100ug | EUR 663 |
Tissue Factor (F3) Antibody |
|||
20-abx303791 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx132340 | Abbexa |
|
|
Tissue Factor (F3) Antibody |
|||
abx117088-100ug | Abbexa | 100 ug | EUR 467 |
Tissue Factor (TF) Antibody |
|||
20-abx104870 | Abbexa |
|
|
Tissue Factor (F3) Antibody |
|||
20-abx100873 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx100874 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx100875 | Abbexa |
|
|
Tissue Factor (F3) Antibody |
|||
20-abx100876 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx100877 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx100878 | Abbexa |
|
|
Tissue Factor (F3) Antibody |
|||
abx037991-100ug | Abbexa | 100 ug | EUR 391 |
Tissue Factor (F3) Antibody |
|||
20-abx001211 | Abbexa |
|
|
Tissue Factor (CD142) Antibody |
|||
abx411647-01mg | Abbexa | 0.1 mg | EUR 439 |
Tissue Factor (CD142) Antibody |
|||
abx414339-02mg | Abbexa | 0.2 mg | EUR 565 |
Tissue Factor (TF) Antibody |
|||
20-abx270078 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx270129 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx270230 | Abbexa |
|
|
Tissue factor (F3) Antibody |
|||
20-abx323788 | Abbexa |
|
|
Tissue factor (F3) Antibody |
|||
20-abx339467 | Abbexa |
|
|
Tissue Factor (CD142) Antibody |
|||
abx140398-01mg | Abbexa | 0.1 mg | EUR 356 |
Tissue Factor (CD142) Antibody |
|||
20-abx141195 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx178602 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx178604 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx174801 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx174802 | Abbexa |
|
|
Tissue Factor (TF) Antibody |
|||
20-abx174803 | Abbexa |
|
|
Tissue factor (F3) Antibody |
|||
20-abx210516 | Abbexa |
|
|
Tissue factor (F3) Antibody |
|||
20-abx325045 | Abbexa |
|
|
Tissue Factor Conjugated Antibody |
|||
C49112 | SAB | 100ul | EUR 397 |
Tissue Factor antibody (HRP) |
|||
60R-1016 | Fitzgerald | 200 ug | EUR 358 |
Description: Sheep polyclonal Tissue Factor antibody (HRP) conjugated |
Tissue Factor antibody (FITC) |
|||
60R-1056 | Fitzgerald | 100 ug | EUR 418 |
Description: Sheep polyclonal Tissue Factor antibody (FITC) conjugated |
Tissue Factor antibody (biotin) |
|||
60R-1057 | Fitzgerald | 100 ug | EUR 418 |
Description: Sheep polyclonal Tissue Factor antibody (biotin) conjugated |
Polyclonal Goat Anti-Tissue Factor Pathway Inhibitor Antibody |
|||
APG00335G | Leading Biology | 0.1mg | EUR 484 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-Tissue Factor Pathway Inhibitor . This antibody is tested and proven to work in the following applications: |
Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280 |
Polyclonal Goat anti-GST μ-form |
|||
GST-ANTI-2 | Detroit R&D | 50 uL | EUR 280 |
Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 280 |
Mouse Monoclonal Anti-Human Tissue Factor IgG |
|||
TIF11-M | Alpha Diagnostics | 100 ug | EUR 482 |
Sheep anti-Human Tissue Factor Pathway Inhibitor polyclonal antibody |
|||
CABT-L505 | Creative Diagnostics | 10 mg | EUR 663 |
Tissue Factor (F3) Antibody (HRP) |
|||
20-abx303792 | Abbexa |
|
|
Tissue Factor (F3) Antibody (FITC) |
|||
20-abx303793 | Abbexa |
|
|
Tissue Factor (F3) Antibody (Biotin) |
|||
20-abx303794 | Abbexa |
|
|
Tissue Factor (TF) Antibody Pair |
|||
20-abx370347 | Abbexa |
|
|
Tissue Factor (CD142) Antibody (FITC) |
|||
abx414337-01mg | Abbexa | 0.1 mg | EUR 509 |
Tissue Factor (CD142) Antibody (FITC) |
|||
abx414338-25ug | Abbexa | 25 ug | EUR 272 |
Tissue Factor (TF) Antibody (FITC) |
|||
20-abx274001 | Abbexa |
|
|
Tissue Factor (TF) Antibody (FITC) |
|||
20-abx274137 | Abbexa |
|
|
Tissue Factor (TF) Antibody (FITC) |
|||
20-abx270376 | Abbexa |
|
|
Tissue Factor (TF) Antibody (FITC) |
|||
20-abx270427 | Abbexa |
|
|
Tissue Factor (TF) Antibody (FITC) |
|||
20-abx270528 | Abbexa |
|
|
Tissue Factor (TF) Antibody (APC) |
|||
20-abx270608 | Abbexa |
|
|
Tissue Factor (TF) Antibody (APC) |
|||
20-abx270659 | Abbexa |
|
|
Tissue Factor (TF) Antibody (APC) |
|||
20-abx270760 | Abbexa |
|
|
Tissue Factor (TF) Antibody (PE) |
|||
20-abx270840 | Abbexa |
|
|
Tissue Factor (TF) Antibody (PE) |
|||
20-abx270891 | Abbexa |
|
|
Tissue Factor (TF) Antibody (PE) |
|||
20-abx270992 | Abbexa |
|
|
Tissue Factor (TF) Antibody (Biotin) |
|||
20-abx271994 | Abbexa |
|
|
Tissue Factor (TF) Antibody (Biotin) |
|||
20-abx272699 | Abbexa |
|
|
Tissue Factor (TF) Antibody (Biotin) |
|||
20-abx273044 | Abbexa |
|
|
Tissue Factor (TF) Antibody (Biotin) |
|||
20-abx273176 | Abbexa |
|
|
Tissue Factor (TF) Antibody (FITC) |
|||
20-abx273794 | Abbexa |
|
|
Tissue Factor (TF) Antibody (APC) |
|||
20-abx178603 | Abbexa |
|
|
Mouse Tissue Factor (TF) Antibody |
|||
32800-05111 | AssayPro | 150 ug | EUR 261 |
Human Tissue Factor (TF) Antibody |
|||
11611-05011 | AssayPro | 150 ug | EUR 217 |
Tissue Factor recombinant monoclonal antibody |
|||
A5658 | Bimake | 100ul X 3 | EUR 595 |
Description: A recombinant monoclonal antibody from rabbit against human Tissue Factor for WB, IHC, IF,ELISA |
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx131768 | Abbexa |
|
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
20-abx132084 | Abbexa |
|
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
20-abx132085 | Abbexa |
|
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
20-abx132086 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx132193 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx132350 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx132360 | Abbexa |
|
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
20-abx129517 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx125726 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx125727 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx125728 | Abbexa |
|
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
20-abx116110 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx123700 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx104836 | Abbexa |
|
|
Tissue Factor Pathway Inhibitor (TFPI) Antibody |
|||
20-abx104947 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx109670 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx103225 | Abbexa |
|
|
Connective Tissue Growth Factor (CTGF) Antibody |
|||
20-abx103226 | Abbexa |
|
|
Learning communities might symbolize a mechanism that facilitates data alternate and information sharing amongst completely different suppliers. As PCPs usually play a essential position caring for sufferers with genetic issues in underserved areas, boundaries to main care-medical genetics integration should be addressed to enhance entry. Strategies, similar to telegenetics, promotion of evidence-based tips, point-of-care danger evaluation instruments, tailor-made schooling in genetics-related subjects, and different system-level methods, will facilitate higher genetics and main care integration, which in flip, might enhance genetic service supply to sufferers residing in underserved communities.